AstraZeneca seeks US emergency approval for Covid-19 antibody cocktail

As treatment options for the pandemic expand beyond vaccination, AstraZeneca Plc has proposed an antibody cocktail for emergency permission in the United States to prevent Covid-19 infection.

It’s the first regulatory submission for the drug, which was found to be 77 percent effective in avoiding symptomatic Covid in a clinical trial including patients with significant infection risk factors.

The mixture can be used to augment immunizations for those who haven’t responded well to vaccinations or to protect those who haven’t been able to get them. The announcement comes only days after Merck & Co. expressed hope that the first Covid tablet will be available shortly. Both therapies have the potential to provide a straightforward approach to treat a large number of patients before they reach the hospital.

“We are one step closer to providing an additional option to help protect against Covid-19 alongside vaccines,” Mene Pangalos, Astra’s executive vice president for biopharmaceuticals research, said in a statement.

Supply arrangements for the drug, known as AZD7442, are currently being discussed with the US government and others across the world. Antibody medicines are more difficult to manufacture in large quantities.

The United States has placed an order for up to 700,000 doses to be delivered in 2021, with the contract’s worth depending on the results of a prior experiment that failed to prove it worked in persons who had been directly exposed to Covid.

In London trade, Astra shares were barely moved.

AddThis Website Tools
Medically Speaking Team

Recent Posts

Why Do Pregnant Women Forget? The Science Behind ‘Momnesia’

Pregnancy is a transformative journey, both physically and emotionally. It brings about significant hormonal, neurological,…

12 mins ago

India Reports Highest Tuberculosis Cases in 2024 Amid Progress in TB Control

India has recorded its highest-ever number of tuberculosis (TB) cases in 2024, with 26.07 lakh…

24 hours ago

Elon Musk’s 120-Hour Workweek: The Dark Reality

Elon Musk is known for his relentless work ethic and high expectations from his teams.…

24 hours ago

Patanjali’s Renogrit: A Breakthrough in Kidney Protection During Cancer Treatment

In 2024, a significant advancement in nephroprotection emerged from Patanjali Research Institute with the development…

1 day ago

Sunita Williams & Butch Wilmore’s 45-Day Rehab After Space Mission

NASA astronauts Sunita Williams and Barry "Butch" Wilmore have returned to Earth after an extended…

1 day ago

Bacterial Meningitis: The Silent Threat You Can’t Ignore

Bacterial meningitis is a life-threatening infection that leads to inflammation of the meninges, the protective…

2 days ago